By working together, we can help take control over the opioid epidemic and be prepared to act in the event of an overdose.
Amneal Pharmaceuticals has launched the “Taking Control Over It” initiative to raise awareness, reduce stigma and educate the community about Naloxone Nasal Spray and opioid emergencies.
Accidental overdoses can happen to anyone, at any time, and in everyday places – from people managing chronic pain at home and work, to children who may mistakenly ingest opioids, adolescents or adults who experiment with drugs, or friends and family members struggling with substance use. Anyone can carry Naloxone Nasal Spray, give it to someone experiencing a known or suspected opioid overdose, and potentially save a life. 2,3
Naloxone Nasal Spray is available over-the-counter (OTC), allowing for quick, easy access without a prescription or pharmacist interaction.
IN CRISIS? HELP IS AVAILABLE. SPEAK WITH SOMEONE TODAY.
SAMHSA National Helpline
If you or someone you know is struggling or in crisis, help is available. Call 1-800-662-4357 or text 988 or chat 988lifeline.org. You’ll be able to speak with a trained crisis counselor any time of day or night.
REFERENCES: 1. Council on Foreign Relations. (2023). Fentanyl and the U.S. Opioid Epidemic. [Backgrounder]. https://www.cfr.org/backgrounder/fentanyl-and-us-opioid-epidemic. Accessed September 2023. 2. Centers for Disease Control and Prevention. (2023) Frequently Asked Questions about Naloxone. Who Can Carry Naloxone? https://www.cdc.gov/stopoverdose/naloxone/faq.html. September 2023. 3. SAFEProject (Stop the Addiction Fatality Epidemic). State Naloxone Access Rules and Resources. https://www.safeproject.us/n loxone/awareness project/state-rules/. September 2023. 4. Centers for Disease Control and Prevention. Drug Overdose. SUDORS Dashboard: Fatal Overdose Data. (2022). Potential opportunities for intervention in 2021. https://www.cdc.gov/drugove dose/fatal/dashboard/index.h ml. February 2024. 5. Centers for Disease Control and Prevention. Reversing Opioid Overdoses with Lifesaving Naloxone. [Fact Sheet]. https://www.cdc.gov/stopove dose/naloxone/pdf/naloxone fact-sheet-508. pdf. September 2023. 6. NPR. (2023). In 2023 fentanyl overdoses ravaged the U.S. and fueled a new culture war fight. https://www.npr.org/2023/1 /28/1220881380/overdose fentanyl-drugs-addiction. Accessed February 2024. 7. American Psychiatric Association. (2022) Opioid Use Disorder. [Backgrounder]. https://www.psychiatry.org/p tients-families/opioid-use disorder. September 2023. 8. United States Drug Enforcement Administration. (2022). DEA Warns of Brightly-Colored Fentanyl Used to Target Young Americans. [Press Release]. https://www.dea.gov/press releases/2022/08/30/dea warns-brightly coloredfentanyl- used-target young-americans. September 2023. 9. National Institutes of Health. (2023). National Library of Medicine. National Center for Biotechnology Information. Opioid Addiction. [StatPearls]. https:// www.ncbi.nlm.nih.gov/books NBK448203/#:~:text=Introd ction-,Opioid%20use%20diso der%20and%20opioid%20add ction%20remain%20at%20ep demic%20levels,opioid%20us %20disorder%20(OUD). September 2023. 10. National Library of Medicine. National Center for Biotechnology Information. Campbell ND. Naloxone as a technology of solidarity: history of opioid overdose prevention. CMAJ. 2019 Aug 26;191(34):E945-E946. doi: 10.1503/cmaj.190257. PMID: 31451527; PMCID: PMC6710079. 11. National Safety Council. Injury Facts. Drug Overdoses. https://injuryfacts.nsc.org/h me-and-community/safety topics/ drugoverdoses/#:~:text=The 2035%2D%20to%2044%2Dy ar,and%20older%20is%20gr wing%20rapidly. September 2023. 12. Chibuzo Iloabuchi, BPharm; Eiman Aboaziza, MD; Xiaohui Zhao, MS, PhD; J. Douglas Thornton, PhD, PharmD, BCPS; Nilanjana Dwibedi, BPharm, MBA, PhD. (2021). “College Students’ Perceptions About Prescription Drug Misuse Among Peers”. American Health & Drug Benefits. Vol 14. No 1. file:///C:/ Users/ghall/Downloads/3 2021_college_students.pdf. September 2023.
Images for reference only. Narcan® is a registered trademark of Emergent Operations Ireland Limited.
© 2024 Amneal Pharmaceuticals LLC. All rights reserved.
PP-NALOX-US-0003 11/2023